About Issar Pharmaceuticals Private Limited
Data last updated: 22 July 2025
Issar Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. The company has been converted to a Limited Liability Partnership (LLP). For the latest details, refer to the successor LLP entity. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 October 1995, the company has been in operation for over 31 years.
Registered with ROC Hyderabad under CIN U24239TG1995PTC022131.
Capital: an authorised share capital of ₹55 Cr and a paid-up capital of ₹55 Cr. It is led by directors Rama Krishna Reddy Isanaka and Isanaka Shaalini.
Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.31 Cr, a growth of 0% compared to the previous year.
The company is associated with 1 brand - Issar Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹28.25 Cr on record.
The company has been converted to a Limited Liability Partnership (LLP). For the most current information, refer to the successor LLP entity registered with MCA. The last known website on record is issar.co.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressH. No. 8 – 2 – 334 Serene Chambers Flat No. W – 301 & 302 Road No.5 Banja, Ra Hills, Hyderabad, Telangana, India – 500034
-
IndustryPharma, Drug Formulation & Development, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24239AP1995PTC022131. The current CIN is U24239TG1995PTC022131, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1995PTC022131 | Current |
| U24239AP1995PTC022131 | Previous |
Associated Brands with Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited operates one associated brand: Issar Pharmaceuticals. These brands represent Issar Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Peptide-based therapeutics are developed for treating multiple diseases. | issar.co.in |
Competitors & Alternatives of Issar Pharmaceuticals Private Limited
Brands and companies operating in the same space as Issar Pharmaceuticals Private Limited include Hummingbird Bioscience, Lyell Immunopharma, LEO Pharma and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Hummingbird Bioscience
|
Antibody drugs for cancer treatment are developed. | Singapore, Singapore, Singapore | 2015 |
Lyell Immunopharma
|
CAR-T and TIL immunotherapies for solid tumors are developed. | San Francisco, United States, United States | 2018 |
LEO Pharma
|
Developer of drugs for treating dermatology diseases | Copenhagen, Denmark, Denmark | 1908 |
GigaGen
|
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | San Francisco, United States, United States | 2011 |
Shattuck Labs
|
An immunotherapy platform for oncology and other diseases is developed. | Austin, United States, United States | 2016 |
Formation Bio
|
AI-powered drug discovery platform for various diseases | New York, United States, United States | 2016 |
Arcutis
|
Immunotherapeutic solutions for dermatological conditions are developed. | Westlake Village, United States, United States | 2016 |
Incyte
|
Small molecules are developed for cancer and skin disease treatments. | Wilmington, United States, United States | 1991 |
TScan Therapeutics
|
T cell-based treatments for immunological and oncological disorders are developed. | Boston, United States, United States | 1995 |
Candel Therapeutics
|
Viral immunotherapies are developed for cancer treatment. | United States | 1999 |
Business Activity of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Issar Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited is audited by REDDY A V & CO for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| REDDY A V & CO | Locked | Locked | Locked |
Complete auditor history for Issar Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited is currently managed by 2 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Rama Krishna Reddy Isanaka
Also directs:
Relief Art Gallery Llp, Issar Pharmaceuticals Llp
|
Director | 02 Sep 1999 | 26 Years 10 Months | As last reported |
|
Isanaka Shaalini
Also directs:
Relief Art Gallery Llp, Issar Pharmaceuticals Llp
|
Director | 12 Apr 2016 | 10 Years 3 Months | As last reported |
Financials of Issar Pharmaceuticals Private Limited FY 2022 filings available
Issar Pharmaceuticals Private Limited reported revenue of ₹8.31 Cr for FY 2024.
Ten-year financial statements for Issar Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Issar Pharmaceuticals Private Limited
Shareholding and ownership data for Issar Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Issar Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2011 | State Bank of India | ₹24.2 Cr | Satisfied |
| 05 Jun 2006 | Uti Bank Limited | ₹1 Cr | Satisfied |
| 12 Nov 2005 | The Karnataka Bank Limited | ₹25 Lakh | Satisfied |
| 12 Nov 2005 | The Karnataka Bank Limited | ₹- | Satisfied |
| 19 Nov 2003 | Karnataka Bank | ₹5.3 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Issar Pharmaceuticals Private Limited
View historical data on people associated with Issar Pharmaceuticals Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Issar Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Issar Pharmaceuticals Private Limited
GST registrations and filing compliance for Issar Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Issar Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Issar Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Issar Pharmaceuticals Private Limited
MSME payment history for Issar Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Issar Pharmaceuticals Private Limited
Corporate group structure for Issar Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Issar Pharmaceuticals Private Limited
MCA filings and documents for Issar Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Issar Pharmaceuticals Private Limited
Recent News on Issar Pharmaceuticals Private Limited
Frequently Asked Questions about Issar Pharmaceuticals Private Limited
Issar Pharmaceuticals Private Limited has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Issar Pharmaceuticals Private Limited is a former company now converted to LLP, previously operating as a private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 31 October 1995 and is registered under CIN U24239TG1995PTC022131. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Issar Pharmaceuticals Private Limited is U24239TG1995PTC022131. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The current directors of Issar Pharmaceuticals Private Limited are:
- Rama Krishna Reddy Isanaka - Director
- Isanaka Shaalini - Director
The primary industry of Issar Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development.
Issar Pharmaceuticals Private Limited was incorporated on 31 October 1995. Registered with ROC Hyderabad.